Rosty Raykov - Apr 4, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Rostislav Raykov
Stock symbol
FENC
Transactions as of
Apr 4, 2024
Transactions value $
-$958,669
Form type
4
Date filed
4/5/2024, 04:56 PM
Previous filing
Apr 3, 2024
Next filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale -$159K -14.6K -5.28% $10.89 261K Apr 4, 2024 Direct F1
transaction FENC Common shares Sale -$324K -29.7K -11.36% $10.89 232K Apr 4, 2024 Direct F2
transaction FENC Common shares Sale -$476K -44.3K -19.11% $10.75 187K Apr 5, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.
F2 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.
F3 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.